Multiple Management Modalities in Esophageal Cancer: Combined Modality Management Approaches
Open Access
- 1 April 2004
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 9 (2) , 147-159
- https://doi.org/10.1634/theoncologist.9-2-147
Abstract
Learning Objectives: After completing this course, the reader will be able to: Outline the relative merits of definitive radiation alone or as a preoperative or postoperative treatment for esophageal cancer versus combined chemoradiation in these settings. Discuss the limitations of our understanding of the radiation dose-response relationship in esophageal cancer. Appreciate the merits of chemoradiation as definitive treatment for esophageal cancer versus its use as an adjuvant to surgery. Access and take the CME test online and receive one hour of AMA PRA category 1 credit at http://CME.TheOncologist.com The overall success rate nationally in treating esophageal carcinomas remains poor, with over 90% of patients succumbing to the disease. In part I of this two-part series, we explored epidemiology, presentation and progression, work-up, and surgical approaches. In part II, we explore the promising suggestions of integrating chemotherapy and radiation therapy into the multimodal management of esophageal cancers. Alternative approaches to resection alone have been sought because of the overall poor survival rates of esophageal cancer patients, with failures occurring both local-regionally and distantly. Concomitant chemotherapy and radiation therapy (XRT) have been shown, by randomized trial, to be more effective than XRT alone in treating unresectable esophageal cancers and also have shown promise as a neoadjuvant treatment when combined with surgery in the multimodal treatment of this disease. Various studies have also addressed issues such as preoperative chemotherapy, radiation dose escalation, chemotherapy/XRT as a definitive treatment versus use as a surgical adjuvant, and alternative chemotherapy regimens. There are suggestions of some progress, but this remains a difficult problem area in which management is continuing to evolve.Keywords
This publication has 76 references indexed in Scilit:
- Oxaliplatin in Combination With Protracted-Infusion Fluorouracil and Radiation: Report of a Clinical Trial for Patients With Esophageal CancerJournal of Clinical Oncology, 2002
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002
- Neoadjuvant Chemoradiation Therapy in Patients with Surgically Treated Esophageal CancerActa Oncologica, 2001
- Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity?The Japanese Journal of Thoracic and Cardiovascular Surgery, 1999
- Does preoperative chemotherapy cause adverse effects on the perioperative course of patients undergoing esophagectomy for carcinoma?The Japanese Journal of Thoracic and Cardiovascular Surgery, 1999
- Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junctionEuropean Journal Of Cancer, 1995
- Induction chemotherapy in the treatment of patients with carcinoma of the esophagusJournal of Surgical Oncology, 1994
- Long-Term Follow-Up of Neoadjuvant Chemotherapy with 5-Fluorouracil and Cisplatin with Surgical Resection and Possible Postoperative Radiotherapy and /or Chemotherapy in Squamous Cell Carcinoma of the EsophagusCancer Investigation, 1993
- Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancerWorld Journal of Surgery, 1992
- A pilot study of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocarcinoma of the esophagusCancer, 1991